Apoptosis modulators in the therapy of neurodegenerative diseases

Author： Deigner H-P.   Haberkorn U.   Kinscherf R.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 747-764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 8, 2011-04 ,pp. : 1068-1086

Bentham Science Publishers

Access to resources Recommend Favorite

Nanotechnology and Antioxidant Therapy: An Emerging Approach for Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 38, 2014-12 ,pp. : 4311-4327

Bentham Science Publishers

Access to resources Recommend Favorite

Potentials of ES Cell Therapy in Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 14, Iss. 36, 2008-12 ,pp. : 3873-3879

Bentham Science Publishers

Access to resources Recommend Favorite

Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 13, Iss. 2, 2015-08 ,pp. : 93-98

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on Development and Regulation of Therapeutic Products for CED-Based Therapy of Neurodegenerative Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 6, 2016-05 ,pp. : 495-512

Bentham Science Publishers

Access to resources Recommend Favorite